Submission Details
| 510(k) Number | K223289 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2022 |
| Decision Date | December 23, 2022 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K223289 is an FDA 510(k) clearance for the Access Vitamin B12, a Radioassay, Vitamin B12 (Class II — Special Controls, product code CDD), submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on December 23, 2022, 59 days after receiving the submission on October 25, 2022. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1810.
| 510(k) Number | K223289 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2022 |
| Decision Date | December 23, 2022 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CDD — Radioassay, Vitamin B12 |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1810 |